Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients
- PMID: 26567156
- DOI: 10.1182/blood-2015-08-662130
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical